Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The results of this study are consistent with effects observed in clinical trials in obese patients, said Penny Ward, an independent pharmaceutical physician and visiting professor in pharmaceutical medicine at King's College London in the U.K
Preclinical studies have validated the therapeutic potential of these compounds for the treatment of obesity and diabetes
Heres a monthly cost breakdown
A 2022 study conducted in Jakarta found that the order of your food matters
GLP-1 households decreased food spending by -1.6% in the first nine months of the year versus a year agothree times faster than non-GLP-1 households (-0.5%)
They're offered in several brand name forms, like Ozempic, where semaglutide is the main substance, or Zepbound, where tirzepatide is the main substance
US$ 24.39
US$ 20.12
US$ 23.99
US$ 24.84
